Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818321 · ClinicalTrials.gov registry record · Phase 2
Urinary Track Infection Prevention After Urogynecological Surgery
A Phase 2 study, sponsored by TriHealth.
- Completed
- Registry status
- Phase 2
- Development phase
- 185
- Enrollment target
NCT03818321: Completed Phase 2 study, sponsored by TriHealth.
NCT03818321 is a Phase 2 study that has completed, run by TriHealth. The registered enrollment target is 185 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818321, a Phase 2 study, has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 185 participants
- Enrollment target
Study Summary
This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after pelvic reconstructive surgery.
Primary Outcome
Incidence of UTIs will be diagnosed at one week post-op visit.
Interventions
- DRUG Placebo tablet
- DRUG Methenamine Hippurate 1 g tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2019-06-17 |
| Est. Completion | 2021-07-01 |
| Phase | Phase 2 |
What the finished NCT03818321 record still lists
NCT03818321 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (39% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo tablet is the first listed.
NCT03818321 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03818321 about?
NCT03818321 is a clinical study titled "Urinary Track Infection Prevention After Urogynecological Surgery". This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after ...
What is the current status of trial NCT03818321?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 185 participants. The study started on 2019-06-17. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03818321?
The interventions under investigation include: Placebo tablet (DRUG), Methenamine Hippurate 1 g tablet (DRUG).
Who is sponsoring clinical trial NCT03818321?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03818321's enrollment target sits among peer trials
185 357th of 2000 higher than 1,641 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI